Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Celemiab International Ab |
| Country | Sweden |
| Start Date | Jun 08, 2021 |
| End Date | Dec 08, 2021 |
| Duration | 183 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2021-02119_Vinnova |
Purpose and goal: ** Denna text är maskinöversatt **
The goal was to establish a clear IP strategy, this is in place including a routine for continuously working with IP issues. Expected results and effects: ** Denna text är maskinöversatt **
The documented IP strategy helps us to effectively invest our funds in a consistent way to build IP value in the company in both the short and long term. It has already helped us in a number of decisions. Approach and implementation: ** Denna text är maskinöversatt **
The project has had a clear phase division, part 1 Analysis: identification and ownership issues Internally. Part 2 Strategic analysis, part 3 Development of strategy and plan for implementation. All three parts have added great value, first a clear picture of the current situation and the IP in the company, part 2 a picture of opportunities in the market and the competitive situation and finally the development of a strategy with clearly identified decision bases for implementation.
Celemiab International Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant